FOLD News and Press, Amicus Therapeutics Inc. From 11/11/21

PHILADELPHIA, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that members of the Amicus senior leadership team will participate in a fireside chat at the Stifel 2021 Virtual Healthcare Conference on Tuesday, November 16, 2021 at 8:00 a.m. E.T. A l...

Image source: The Motley Fool. Amicus Therapeutics, inc (NASDAQ: FOLD) Q3 2021 Earnings Call Nov 9, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Amicus Therapeutics, inc (FOLD) Q3 2021 Earnings Call Transcript

The following slide deck was published by Amicus Therapeutics, Inc. in conjunction with their 2021 Q3 earnings call. For further details see: Amicus Therapeutics, Inc. 2021 Q3 - Results - Earnings Call Presentation

Amicus Therapeutics, Inc. (FOLD) Q3 2021 Earnings Conference Call November 9, 2021 8:30 AM ET Company Participants Andrew Faughnan – Head-Investor Relations John Crowley – Chairman and Chief Executive Officer Bradley Campbell – President and Chief Operating Officer Jeff C...

Amicus Therapeutics (NASDAQ:FOLD): Q3 GAAP EPS of -$0.19 misses by $0.02. Revenue of $79.54M (+17.9% Y/Y) misses by $0.79M. Press Release Cash, cash equivalents, and marketable securities totaled $557.0 million at September 30, 2021, compared to $483.3 million at December 31, 2020 For furth...

3Q21 Total Galafold ® Revenue of $79.5M – an 18% increase over 3Q20 Reiterating 2021 Revenue Guidance of $300M-$315M AT-GAA BLA and NDA for Pompe Disease Accepted for Review by the U.S. FDA; Marketing Authorization ...

Amicus Therapeutics (NASDAQ:FOLD) is scheduled to announce Q3 earnings results on Tuesday, November 9th, before market open. The consensus EPS Estimate is -$0.18 and the consensus Revenue Estimate is $80.33M (+19.1% Y/Y). Over the last 1 year, FOLD has beaten EPS estimates 25% of the time and...

ADT,AGEN,AGTC,ALLT,APRN,AUD,OTCPK:BAYZF,BHVN,BNTX,BSY,CAH,CANO,CCO,CEVA,CNCE,CORR,DCTH,DHI,DRNA,EBIX,ECOM,EGRX,EPZM,EXK,FOLD,GILT,GLNG,GOL,HAE,HAIN,HGV,HUYA,IGT,IIVI,INSW,ISEE,ITCI,KNDI,KPLT,MIDD,MLCO,MNTV,MRNS,MRSN,MSGE,OTCPK:NSANY,NSPR,NUWE,OCGN,OESX,OSG,OWL,PLTR,PRPL,PRTY,QTNT,SATS,SEAS,SE...

PHILADELPHIA, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Tuesday, November 9, 2021 at 8:30 a.m. ET to discuss financial results for the third quarter ended September 30, 2021. ...

Recording the biggest intraday loss in nearly six months, Intellia Therapeutics (NTLA -10.7%) has shed all the gains made since late June when the company and its partner Regeneron (NASDAQ:REGN) showed promising in-vivo CRISPR-based genome editing data for the first time in humans. The w...